Advertisement

High through-put sequencing analysis of changes in oral flora in rats before and after zoledronate administration

      Abstract

      The aim of this study was to compare the changes in the oral flora of Sprague-Dawley rats before intraperitoneal injection of zoledronic acid, 6 weeks and 12 weeks after injection. Clinically, some antibiotics effectively treat patients with medicine-related osteonecrosis of the jaws (MRONJ), but the effect of broad-spectrum antibiotics for osteomyelitis of the jaw is not obvious. We therefore speculated that MRONJ may have some dominant bacteria. We used 12 healthy rats for the experiment. One rat was used for haematoxylin and eosin staining, three were used for gene analysis, three for signal molecule research, and five for 16SrDNA high-pass sequencing to compare the changes of flora before intraperitoneal injection of zoledronic acid, and 6 and 12 weeks after injection once every three days. Alpha and beta analysis was used for sequencing data. Analysis of the flora showed that the alpha diversity of the bacteria of rats injected with zoledronic acid was significantly higher than it was before injection (p < 0.05). At the phylum level, Bacteroidetes at 6 and 12 weeks of injection were significantly higher than those before injection (p < 0.05). At the genus level, the proportions of Novophingobium, Dubosiella, Mannheimia, Prevotella, Brevundimonas, and Bacteroides were higher than they were before injection (p < 0.05). The proportions of Lactobacillus, Mannheimia, Brevundimonas, Bacteroides, Roseovarius, Salegentibacter, Marinobacter, and Granulicatella in rats injected for 12 weeks were higher than those before injection (p < 0.05). Zoledronic acid can change the structure of oral flora in SD rats, in which Bacteroides increased and Actinomycetes decreased.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to British Journal of Oral and Maxillofacial Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Marx R.E.
        Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic.
        J Oral Maxillofac Surg. 2003; 61: 1115-1117
        • Santini D.
        • Zoccoli A.
        • Gregorj C.
        • et al.
        Zoledronic acid induces a significant decrease of circulating endothelial cells and circulating endothelial precursor cells in the early prostate cancer neoadjuvant setting.
        Oncology. 2013; 85: 342-347
        • De Bruyn L.
        • Coropciuc R.
        • Coucke W.
        • et al.
        Microbial population changes in patients with medication-related osteonecrosis of the jaw treated with systemic antibiotics.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2018; 125: 268-275
        • Baron R.
        • Ferrari S.
        • Russell R.G.
        Denosumab and bisphosphonates: different mechanisms of action and effects.
        Bone. 2011; 48: 677-692
        • De Ceulaer J.
        • Tacconelli E.
        • Vandecasteele S.J.
        Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): the missing link?.
        Eur J Clin Microbiol Infect Dis. 2014; 33: 1873-1880
        • Li C.L.
        • Seneviratne C.J.
        • Huo L.
        • et al.
        Impact of Actinomyces naeslundii on bisphosphonate-related osteonecrosis of the jaws in ovariectomized rats with periodontitis.
        J Craniomaxillofac Surg. 2015; 43: 1662-1669
        • Lesclous P.
        • Abi Najm S.
        • Carrel J.P.
        • et al.
        Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?.
        Bone. 2009; 45: 843-852
        • Naik N.H.
        • Russo T.A.
        Bisphosphonate-related osteonecrosis of the jaw: the role of actinomyces.
        Clin Infect Dis. 2009; 49: 1729-1732
        • Sedghizadeh P.P.
        • Kumar S.K.
        • Gorur A.
        • et al.
        Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy.
        J Oral Maxillofac Surg. 2008; 66: 767-775
        • Russmueller G.
        • Seemann R.
        • Weiss K.
        • et al.
        The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection.
        Sci Rep. 2016; 6: 31604
        • Trojánek Z.
        • Kovařík A.
        • Španová A.
        • et al.
        Application of magnetic polymethacrylate-based microspheres for the isolation of DNA from raw vegetables and processed foods of plant origin.
        J Process Preserv. 2018; 42: e13384
        • Hallmer F.
        • Bjørnland T.
        • Andersson G.
        • et al.
        Bacterial diversity in medication-related osteonecrosis of the jaw.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2017; 123: 436-444
        • Zaura E.
        • Keijser B.J.
        • Huse S.M.
        • et al.
        Defining the healthy “core microbiome” of oral microbial communities.
        BMC Microbiol. 2009; 9: 259
        • Wei X.
        • Pushalkar S.
        • Estilo C.
        • et al.
        Molecular profiling of oral microbiota in jawbone samples of bisphosphonate-related osteonecrosis of the jaw.
        Oral Dis. 2012; 18: 602-612
        • Li W.
        • Ma Z.S.
        FBA Ecological guild: trio of Firmicutes-Bacteroidetes alliance against Actinobacteria in human oral microbiome.
        Sci Rep. 2020; 10: 287
        • Hansen T.
        • Kunkel M.
        • Springer E.
        • et al.
        Actinomycosis of the jaws—histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis.
        Virchows Arch. 2007; 451: 1009-1017
        • Torres P.J.
        • Thompson J.
        • Mclean J.S.
        • et al.
        Discovery of a novel periodontal disease-associated bacterium.
        Microb Ecol. 2019; 77: 267-276
        • van Winkelhoff A.J.
        • Steenbergen T.J.
        • de Graaff J.
        The role of black-pigmented Bacteroides in human oral infections.
        J Clin Periodontol. 1988; 15: 145-155
        • Loesche W.J.
        • Socransky S.S.
        • Gibbons R.J.
        Bacteroides oralis, proposed new species isolated from the oral cavity of man.
        J Bacteriol. 1964; 88: 1329-1337
        • Olsen I.
        Chemotaxonomy of Bacteroides: a review.
        Acta Odontol Scand. 1994; 52: 354-367
        • Lamont R.J.
        • Hajishengallis G.
        Polymicrobial synergy and dysbiosis in inflammatory disease.
        Trends Mol Med. 2015; 21: 172-183
        • Klima C.L.
        • Alexander T.W.
        • Read R.R.
        • et al.
        Genetic characterization and antimicrobial susceptibility of Mannheimia haemolytica isolated from the nasopharynx of feedlot cattle.
        Vet Microbiol. 2011; 149: 390-398
        • Colombo A.P.
        • Boches S.K.
        • Cotton S.L.
        • et al.
        Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray.
        J Periodontol. 2009; 80: 1421-1432
        • Ge X.
        • Rodriguez R.
        • Trinh M.
        • et al.
        Oral microbiome of deep and shallow dental pockets in chronic periodontitis.
        PLoS One. 2013; 8: e65520